Researchers find a potential therapeutic target to prevent dissemination of cancer cells in the central nervous system

by Instituto de Medicina MolecularGraphical abstract. Credit:Neuro-Oncology Advances(2023). DOI: 10.1093/noajnl/vdad048A new study led by Cláudia C. Faria, researcher in the lab of João Ta

Updated on: February 23,2024

Researchers find a potential therapeutic target to prevent dissemination of cancer cells in the central nervous system

by Instituto de Medicina MolecularGraphical abstract. Credit:Neuro-Oncology Advances(2023). DOI: 10.1093/noajnl/vdad048A new study led by Cláudia C. Faria, researcher in the lab of João Ta

Updated on:February 23,2024

Study shows immunotherapy may benefit a subset of patients with penile cancer

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPenile cancer is a rare disease with approximately 2,070 new cases each year in the U.S. Treatment options are limited and typical

Updated on: January 22,2024

Study shows immunotherapy may benefit a subset of patients with penile cancer

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPenile cancer is a rare disease with approximately 2,070 new cases each year in the U.S. Treatment options are limited and typical

Updated on:January 22,2024

Japan to trial 'world's first urine test' to spot cancer

Credit: CC0 Public DomainA Japanese firm is poised to carry out what it hailed as the world's first experiment to test for cancer using urine samples, which would greatly facilitate screening for

Updated on: March 01,2024

Japan to trial 'world's first urine test' to spot cancer

Credit: CC0 Public DomainA Japanese firm is poised to carry out what it hailed as the world's first experiment to test for cancer using urine samples, which would greatly facilitate screening for

Updated on:March 01,2024

Researchers identify novel oncogenic function for receptor linked to Alzheimer's disease

by University of TurkuCredit: CC0 Public DomainCommon and rare SORLA single nucleotide polymorphisms have been associated with the development of Alzheimer's disease. So far, SORLA has been m

Updated on: March 12,2024

Researchers identify novel oncogenic function for receptor linked to Alzheimer's disease

by University of TurkuCredit: CC0 Public DomainCommon and rare SORLA single nucleotide polymorphisms have been associated with the development of Alzheimer's disease. So far, SORLA has been m

Updated on:March 12,2024

Intraventricular immunovirotherapy: A translational step forward

by Impact JournalsPutative mechanisms of toxicity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28343A new research perspective titled "Intraventricular immunovirotherapy; a tran

Updated on: January 02,2024

Intraventricular immunovirotherapy: A translational step forward

by Impact JournalsPutative mechanisms of toxicity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28343A new research perspective titled "Intraventricular immunovirotherapy; a tran

Updated on:January 02,2024

Five ways research can prevent cancer

by Sophia Lowes,Cancer Research UKCredit: Jill WatsonWe recently published landmark researchshowing how lifestyle can influence our risk of cancer, and what factors could help prevent it.

Updated on: March 01,2024

Five ways research can prevent cancer

by Sophia Lowes,Cancer Research UKCredit: Jill WatsonWe recently published landmark researchshowing how lifestyle can influence our risk of cancer, and what factors could help prevent it.

Updated on:March 01,2024

First-line regimens with endocrine therapy show benefits in breast cancer

by Lori SolomonFirst-line regimens with endocrine therapy (ET) may be associated with benefits among patients with human epidermal growth factor receptor 2-positive (ERBB2-positive [formerly HER2-posi

Updated on: February 03,2024

First-line regimens with endocrine therapy show benefits in breast cancer

by Lori SolomonFirst-line regimens with endocrine therapy (ET) may be associated with benefits among patients with human epidermal growth factor receptor 2-positive (ERBB2-positive [formerly HER2-posi

Updated on:February 03,2024

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Updated on: March 30,2024

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Updated on:March 30,2024

Survivorship standards help address the distinct needs of adult cancer survivors

byAmerican College of SurgeonsCredit: Thirdman from PexelsWith the number of adult cancer survivors in the United States expected to reach 23 million by 2032, the long-term needs of this populat

Updated on: July 05,2024

Survivorship standards help address the distinct needs of adult cancer survivors

byAmerican College of SurgeonsCredit: Thirdman from PexelsWith the number of adult cancer survivors in the United States expected to reach 23 million by 2032, the long-term needs of this populat

Updated on:July 05,2024

New study estimates preventable cancer burden linked to poor diet in the US

by Tufts UniversityA new study estimates that 5.2 percent of new invasive cancer cases reported in 2015 are associated with poor diets. Credit: Nako Kobayashi/Tufts UniversityA new modeling study

Updated on: May 21,2024

New study estimates preventable cancer burden linked to poor diet in the US

by Tufts UniversityA new study estimates that 5.2 percent of new invasive cancer cases reported in 2015 are associated with poor diets. Credit: Nako Kobayashi/Tufts UniversityA new modeling study

Updated on:May 21,2024

Research suggests a new approach for treatment-resistant breast cancers

by Louisiana State UniversityCB-103 shows synergy with paclitaxel and fulvestrant in breast cancer cell lines. TNBC (HCC1187) and ER+ BC (MCF-7) cells were treated with combinations of CB-103 (15

Updated on: February 18,2024

Research suggests a new approach for treatment-resistant breast cancers

by Louisiana State UniversityCB-103 shows synergy with paclitaxel and fulvestrant in breast cancer cell lines. TNBC (HCC1187) and ER+ BC (MCF-7) cells were treated with combinations of CB-103 (15

Updated on:February 18,2024

Lost metabolic fitness of CAR NK cells is key mechanism of tumor resistance, study discovers

byUniversity of Texas M. D. Anderson Cancer CenterCAR-NK cells have a distinct single-cell transcriptome and metabolic profile. Credit:Science Advances(2023). DOI: 10.1126/sciadv.add

Updated on: January 23,2024

Lost metabolic fitness of CAR NK cells is key mechanism of tumor resistance, study discovers

byUniversity of Texas M. D. Anderson Cancer CenterCAR-NK cells have a distinct single-cell transcriptome and metabolic profile. Credit:Science Advances(2023). DOI: 10.1126/sciadv.add

Updated on:January 23,2024